Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Characterization of Central and Nasal Orbital Adipose Stem Cells and their Neural Differentiation Footprints.

Sanie-Jahromi F., Nowroozzadeh MH., Shaabanian M., Khademi B., Owji N., Mehrabani D.

Laboratory Study on Ankle & Foot, published in Curr Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Curr Stem Cell Res Ther (2024)
Country
United Arab Emirates
Reported sample size
—
Source database
PubMed
PMID
37670706
DOI
10.2174/1574888X19666230905114246
Citations
3

Abstract (original English)

Background The unique potential of stem cells to restore vision and regenerate damaged ocular cells has led to the increased attraction of researchers and ophthalmologists to ocular regenerative medicine in recent decades. In addition, advantages such as easy access to ocular tissues, non-invasive follow-up, and ocular immunologic privilege have enhanced the desire to develop ocular regenerative medicine. Objective This study aimed to characterize central and nasal orbital adipose stem cells (OASCs) and their neural differentiation potential. Methods The central and nasal orbital adipose tissues extracted during an upper blepharoplasty surgery were explant-cultured in Dulbecco's Modified Eagle Medium (DMEM)/F12 supplemented with 10% fetal bovine serum (FBS). Cells from passage 3 were characterized morphologically by osteogenic and adipogenic differentiation potential and by flow cytometry for expression of mesenchymal (CD73, CD90, and CD105) and hematopoietic (CD34 and CD45) markers. The potential of OASCs for the expression of NGF, PI3K , and MAPK and to induce neurogenesis was assessed by real-time PCR. Results OASCs were spindle-shaped and positive for adipogenic and osteogenic induction. They were also positive for mesenchymal and negative for hematopoietic markers. They were positive for NGF expression in the absence of any significant alteration in the expression of PI3K

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAdipose TissueCell DifferentiationCells, CulturedStem CellsAdipogenesisNeurogenesisOsteogenesisMesenchymal Stem CellsNeurons

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research